HaystackAnalytics, a genomics-based diagnostic solutions, has secured a patent for its innovative “Systems and Methods for Secure Genomic Analysis Using a Specialised Edge Computing Device.” This technology allows for real-time genomic analysis at the point of use, eliminating the need for complex infrastructure and specialised personnel, and offering standardised genomic analysis that is more accessible and cost-effective.
The patented technology enables laboratories and hospitals to perform accurate genomic analysis without heavy investments in high-performance computing systems or reliance on bioinformatics experts. By decentralising genomic analysis, this solution provides real-time insights, improving disease diagnosis and treatment across healthcare settings.
Dr. Anirvan Chatterjee, CEO & Co-founder of HaystackAnalytics, highlighted the significance of the patent in India’s growing biotech and genomics sector. “This technology is a game-changer, enabling faster and more accessible genomic analysis, which is crucial for rare disease diagnosis, AI-driven healthcare, and improving public health preparedness,” he said. “Our long-term vision is to leverage genomic insights to improve patient outcomes and contribute to the global fight against antimicrobial resistance and infectious diseases.”
With rising concerns over antimicrobial resistance (AMR), tuberculosis (TB), and other emerging diseases, India’s healthcare system requires scalable genomic tools. This patented technology can be deployed seamlessly in hospitals and labs, addressing a critical gap in the accessibility of cutting-edge genomic diagnostics.